He-Jing Wang

6.6k total citations · 2 hit papers
36 papers, 4.4k citations indexed

About

He-Jing Wang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, He-Jing Wang has authored 36 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in He-Jing Wang's work include Immunotherapy and Immune Responses (9 papers), Cutaneous Melanoma Detection and Management (7 papers) and CAR-T cell therapy research (5 papers). He-Jing Wang is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cutaneous Melanoma Detection and Management (7 papers) and CAR-T cell therapy research (5 papers). He-Jing Wang collaborates with scholars based in United States, Australia and United Kingdom. He-Jing Wang's co-authors include Robert M. Elashoff, Donald L. Morton, Dave S.�B. Hoon, Richard Essner, Douglas S. Reintgen, Constantine P. Karakousis, Nicola Mozzillo, John F. Thompson, Daniel F. Roses and Alistair J. Cochran and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Clinical Nutrition.

In The Last Decade

He-Jing Wang

36 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel-Node Biopsy or Nodal Observation in Melanoma

2006 1.2k citations Donald L. Morton, John F. Thompson et al. New England Journal of Medicine profile →
Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma

1999 579 citations Donald L. Morton, John F. Thompson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
He-Jing Wang United States	28	2.6k	1.3k	891	791	705	36	4.4k
Reinhard Horvat Austria	40	1.4k 0.5×	1.8k 1.4×	348 0.4×	1.0k 1.3×	544 0.8×	106	4.2k
Guido Coggi Italy	39	1.6k 0.6×	1.7k 1.4×	575 0.6×	632 0.8×	229 0.3×	102	4.4k
Alexander Schmittel Germany	36	1.9k 0.7×	1.1k 0.8×	450 0.5×	273 0.3×	1.4k 2.0×	100	3.5k
Geneviève Laureys Belgium	39	1.4k 0.5×	2.3k 1.8×	632 0.7×	1.4k 1.7×	463 0.7×	165	5.1k
Jillian M. Birch United Kingdom	42	2.6k 1.0×	2.4k 1.9×	783 0.9×	996 1.3×	206 0.3×	143	7.1k
Cynthia Cohen United States	37	1.5k 0.6×	1.5k 1.1×	662 0.7×	774 1.0×	322 0.5×	139	4.3k
Gal Markel Israel	41	2.5k 1.0×	1.5k 1.2×	509 0.6×	343 0.4×	3.0k 4.2×	126	5.8k
Patricia Pautier France	33	1.8k 0.7×	1.6k 1.3×	476 0.5×	600 0.8×	604 0.9×	200	4.8k
Harald Holte Norway	41	3.2k 1.2×	698 0.6×	257 0.3×	455 0.6×	1.3k 1.8×	248	6.5k
Thomas Filleron France	33	2.1k 0.8×	1.1k 0.9×	351 0.4×	808 1.0×	958 1.4×	222	4.9k

Countries citing papers authored by He-Jing Wang

Since Specialization

Citations

This map shows the geographic impact of He-Jing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He-Jing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He-Jing Wang more than expected).

Fields of papers citing papers by He-Jing Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He-Jing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He-Jing Wang. The network helps show where He-Jing Wang may publish in the future.

Co-authorship network of co-authors of He-Jing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of He-Jing Wang. A scholar is included among the top collaborators of He-Jing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He-Jing Wang. He-Jing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winterhoff, Boris, Habib Hamidi, Chen Wang, et al.. (2016). Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures. Gynecologic Oncology. 141(1). 95–100. 40 indexed citations

Li, Tie, Reshmi Chowdhury, Fei Liu, et al.. (2016). Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro-Oncology. 19(3). now189–now189. 70 indexed citations

Konecny, Gottfried E., Chen Wang, Habib Hamidi, et al.. (2014). Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer. JNCI Journal of the National Cancer Institute. 106(10). 267 indexed citations

Bacchetta, Justine, Katherine Wesseling‐Perry, Beatriz D. Kuizon, et al.. (2013). The Skeletal Consequences of Growth Hormone Therapy in Dialyzed Children. Clinical Journal of the American Society of Nephrology. 8(5). 824–832. 16 indexed citations

Zaritsky, Joshua J., Brian Young, Barbara Gales, et al.. (2010). Reduction of Serum Hepcidin by Hemodialysis in Pediatric and Adult Patients. Clinical Journal of the American Society of Nephrology. 5(6). 1010–1014. 82 indexed citations

Wesseling‐Perry, Katherine, He-Jing Wang, Shobha Sahney, et al.. (2009). Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols. Pediatric Nephrology. 24(7). 1355–1361. 14 indexed citations

Zaritsky, Joshua J., Brian Young, He-Jing Wang, et al.. (2009). Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 4(6). 1051–1056. 260 indexed citations

Konecny, Gottfried E., Rachana Agarwal, Gary Keeney, et al.. (2008). Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Gynecologic Oncology. 109(2). 263–269. 65 indexed citations

Kimura, Takahiro, Richard C. Koya, Laura Anselmi, et al.. (2007). Lentiviral Vectors with CMV or MHCII Promoters Administered In Vivo: Immune Reactivity Versus Persistence of Expression. Molecular Therapy. 15(7). 1390–1399. 35 indexed citations

10.

Rao, Dinesh S., Dorina Gui, Michelle Koski, et al.. (2006). An Inverse Relation Between COX-2 and E-cadherin Expression Correlates With Aggressive Histologic Features in Prostate Cancer. Applied immunohistochemistry & molecular morphology. 14(4). 375–383. 24 indexed citations

11.

Morton, Donald L., John F. Thompson, Alistair J. Cochran, et al.. (2006). Sentinel-Node Biopsy or Nodal Observation in Melanoma. New England Journal of Medicine. 355(13). 1307–1317. 1219 indexed citations breakdown →

12.

Shao, Zhi‐Ming, Perrin H. Beatty, Maryam Sartippour, et al.. (2003). The Use of Oxytocin in Nipple Fluid Aspiration. The Breast Journal. 9(4). 266–268. 12 indexed citations

13.

Hoon, Dave S.�B., et al.. (2001). Molecular Detection of Metastatic Melanoma Cells in Cerebrospinal Fluid in Melanoma Patients. Journal of Investigative Dermatology. 117(2). 375–378. 27 indexed citations

14.

O’Day, Steven, Peter D. Boasberg, Maureen Martin, et al.. (2001). High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer. 92(3). 609–619. 18 indexed citations

15.

Goodman, William G., Sudipta Misra, Anthony A. Portale, et al.. (2000). Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition. American Journal of Clinical Nutrition. 71(2). 560–568. 15 indexed citations

16.

Friedman, Richard L., Scott M. Eisenkop, & He-Jing Wang. (1997). Second-Look Laparotomy for Ovarian Cancer Provides Reliable Prognostic Information and Improves Survival. Gynecologic Oncology. 67(1). 88–94. 19 indexed citations

17.

Eisenkop, Scott M., Richard L. Friedman, & He-Jing Wang. (1995). Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer. 76(9). 1606–1614. 91 indexed citations

18.

Wellisch, David K., Ellen R. Gritz, Wendy S. Schain, He-Jing Wang, & Jessie Siau. (1992). Psychological Functioning of Daughters of Breast Cancer Patients. Psychosomatics. 33(2). 171–179. 102 indexed citations

19.

Gritz, Ellen R., David K. Wellisch, Jessie Siau, & He-Jing Wang. (1990). Long-Term Effects of Testicular Cancer on Marital Relationships. Psychosomatics. 31(3). 301–312. 64 indexed citations

20.

Gritz, Ellen R., David K. Wellisch, He-Jing Wang, et al.. (1989). Long-term effects of testicular cancer on sexual functioning in married couples. Cancer. 64(7). 1560–1567. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact